Product Information
CLORAZEPATE 15 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.8080 per EA under NDC 70954015710. Its NADAC has been published 191 times since Feb 8, 2023.
FDA first approved this application on Jun 16, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954015710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLORAZEPATE DIPOTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA213730FDA Approved
6/16/2022
TE Code
AB
On Market Since
12/16/2022
Pharmacological Classes
Price Statistics
The NADAC for CLORAZEPATE 15 MG TABLET has been published 191 times since Feb 8, 2023, and over the history we have for it it has declined 70.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8080 per EA |
|---|---|
| All-time high | $2.7463 (Feb 15, 2023) |
| All-time low | $0.6724 (Jun 19, 2024) |
| 52-week high | $1.7543 |
| 52-week low | $0.8080 |
| Median price | $1.2599 |
| Average price | $1.3270 |
| Largest weekly change | +94.5% (Mar 20, 2024) |
| Weeks tracked | 191 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clorazepate Dipotassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLORAZEPATE 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 15 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.8080 per EA (NDC 70954015710), effective Sep 30, 2026.
How has the price of CLORAZEPATE 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLORAZEPATE 15 MG TABLET has declined 70.6%. It has been tracked across 191 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for CLORAZEPATE 15 MG TABLET?
Since Feb 8, 2023, the NADAC for CLORAZEPATE 15 MG TABLET has ranged from a low of $0.6724 (Jun 19, 2024) to a high of $2.7463 (Feb 15, 2023), with a median of $1.2599 per EA.
Are there cheaper alternatives to CLORAZEPATE 15 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLORAZEPATE 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLORAZEPATE 15 MG TABLET?
CLORAZEPATE 15 MG TABLET (NDC 70954015710) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.